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WOUND INFECTION RATE IN COLORECTAL SURGERY: A PROSPECTIVE
NON RANDOMIZED TRIAL
Syed Muhammad Amir Zaidi, Wasif Majeed Chaudhry,
Haseeb Anwar Khokhar*, Hamid Majeed, Suhail Aslam Khan. Our Lady of
Lourdes Hospital, Drogheda, Co Louth, Ireland.
Introduction: Negative Pressure Incision care therapy (NPICT) has never
been reported in colorectal surgery. The aim of this trial is to evaluate the
effect of NPICT on wound infection rate.
Methods: 317 consecutive patients underwent major colorectal pro-
cedures in a regional hospital over 3 years by a single team. 104 (32.1%)
patients were excluded on the basis of other complications affecting LOS.
Out of 213 patients included, 71 (33.3%) patients received NPICT, while 142
(66.6%) patients received regular dressings (Non-NPICT group). Study
endpoints were rate of 30-day wound infection rate and LOS.
Results: The mean age was 66.46 (NPICT) and 65.58 (Non-NPICT). Male to
female ratio was 1:1.06(NPICT) and 1:1.04(Non-NPICT). Patients in NPICT
group underwent at least 07 days of incision care therapy. 3 patients (4.2%)
in NPICT group and 29 patients (20.4%) in Non-NPICT group developed
wound complications [p <0.001, RR¼0.68(0.57-0.79), OR¼0.14(0.033-
0.6362)]. The LOS increased from 9±3$22days in the NPICT group and
14±4.31days for Non-NPICT group. Complete healing of wounds occurred
by 31$1±8$22 days in NPICT group.
Conclusions: Use of Negative Pressure Incision care therapy (NPICT)
signiﬁcantly reduces risk of wound infections in high risk colorectal sur-
gical patients thus reducing LOS.
1059: EFFICACY OF ORAL REHYDRATION THERAPY (ORT) IN RESTORING
WATER AND ELECTROLYTE BALANCE POST-COLECTOMY e A BLINDED
PLACEBO-CONTROLLED RANDOMISED CROSS-OVER TRIAL
Sreelakshmi Mallappa*,1, Simon Gabe 1, Robin Phillips 1,
Margaret Robertson 2, Susan Clark 1. 1St Mark's Hospital, Harrow,
Middlesex, UK; 2University of Surrey, Guildford, Surrey, UK.
Introduction: To evaluate the efﬁcacy of oral rehydration therapy (ORT) in
restoring water and electrolyte balance post-colectomy.
Methods: Blinded placebo-controlled randomised cross-over trial. 30
patients with demonstrated hyperaldosteronism from the on-going
observational study were recruited. Patients were randomised to receive
either placebo or ORT ﬁrst in a cross-over trial.
Fasting urine and blood samples were collected to measure sodium loss,
hydration status and renin-angiotensin-aldosterone system (RAAS) acti-
vation. Oral glucose tolerance test was performed. Health related quality of
life (HRQoL) was assessed using SF-36 and FACIT-F questionnaires.
Results: Observational study:60 FAP patients who had undergone
colectomy were recruited. 27 patients (45%) demonstrated fasting
hyperaldosteronism (>250pmol/L) leading to higher urinary losses of
potassium (p¼0.03) and creatinine (p¼0.01). 19 patients 32%) demon-
strated postprandial hypoglycaemia(<3.9mmol/L). Cross-over RCT
Biochemistry results: Data acquired so far in 16 patients (n¼48 clinic
visits) demonstrated fasting plasma aldosterone concentration post-ORT
to be signiﬁcantly lower compared to baseline [189.25 (7.24) vs. 536.25
(12.56) pmol/L; p¼0.05]. HRQoL results: SF 36 & FACIT-F: Post-ORT, pa-
tients reported marked improvement in QoL scores when compared to
baseline.
Conclusions: Colectomy results in metabolic disturbances leading to a
negative impact on Qol. ORT forms a safe and effective intervention to
correct the metabolic disturbances post-colectomy resulting in restoration
of metabolic homeostasis and a positive impact on QoL.
1076: TAKE IT OR LEAVE IT: A MULTI-INSTITUTIONAL STUDY OF MECK-
EL’S DIVERTICULUM
Naomi Fearon*,1, Colin Pierce 1, Helen Mohan 1, Ailin Rogers 1,
Conor Shields 2, Des Winter 1. 1St Vincents University Hospital, Dublin,
Ireland; 2Mater Misericordiae University Hospital, Dublin, Ireland.
Introduction: The management of an incidental Meckels diverticulum
(MD) remains controversial. Current practice guidelines suggests that age
less than 50 years, male sex and diverticulum length greater than 2cm are
factors favouring resection. The aim of this study was to review a regional
experience of resected Meckel's diverticulae.
Methods: All resected specimens over a 17year period (1993-2010) were
identiﬁed from patient clinical records, theatre logbooks, Hospital In-Patient Enquiry data and pathology databases across four hospital sites in
Leinster, Ireland. Patient demographics and clinicopathological charac-
teristics were reviewed.
Results: Ninety-four MD were identiﬁed. The average age at surgery was
43.5 years (range 13-84 years) and 66% of patients were male. Themajority
presented symptomatically (n¼65), with abdominal pain and rectal
bleeding the most common symptoms. Patients presenting symptomati-
cally were signiﬁcantly younger than patients with an incidental ﬁnding of
MD (p¼0.02, Mann-Whitney U test) and 73% of symptomatic patients were
male (p¼0.03, Mann-Whitney U test). Seventy-ﬁve per cent of specimens
were 2cm or greater in length with no difference detected between the
symptomatic and incidental groups. Ectopic mucosa was detected in 21
specimens and no malignancies were detected.
Conclusions: This data suggests the decision to resect should be on an
individual case basis.
1093: A CLINICAL AUDIT OF ENHANCED RECOVERY AFTER SURGERY
(ERAS) PATHWAYS IN COLORECTAL AND HEPATO-PANCREATO-BILLI-
ARY SURGERY AT QUEEN’S MEDICAL CENTRE, NOTTINGHAM UNIVER-
SITY HOSPITAL
Adnan Malik*, Damian Bragg, Charles Maxwell-Armstrong. Queen's
Medical Centre, Nottingham University Hospital, Nottingham, UK.
Introduction: To determine the rate of success of the ERAS pathways in
colorectal and HPB surgery, but also relating compliance and its impact on
ERAS success.
Methods: Pre-, peri- and post-operative data of 56 colorectal and 9 HPB
patients was collected prospectively between October and December 2013.
Primary outcomes of ERAS success (% discharged on or before clinically
expected day) and length of stay (days) were analysed using SPSS version
21.0
Results: ERAS success in colorectal surgery rose to 39.3% after a general
decline from 2010-2012. Mean LOS for open and laparoscopic colorectal
procedures were reduced by 2.8 and 2.6 days respectively. After univariate
analysis 24 protocols were signiﬁcantly associated with colorectal success.
Further multivariate analysis established 12 including PCA or epidural
removal before 12.00am (p¼0.004), urinary catheter removal (p¼0.005)
and length of surgery (p¼0.017). HPB saw a slight drop in ERAS success to
44.4%, only lunch consumption (p¼0.016) was signiﬁcantly associated
with ERAS success after univariate analysis.
Conclusions: Improvement in colorectal ERAS success suggests effective
revision of protocols. As before the HPB results are clinically irrelevant due
to the small sample size. If recommendations put forward are imple-
mented one would expect them to increase future ERAS success.
1116: AVAILABILITY, AND FEASIBILITY OF ROUTINELY MEASURING CO-
MORBIDITY IN A COLORECTAL CANCER MDT
Amin Abukar*, Anthony Ramsanahie, Simon Wong, Kim Martin-Lumbard,
Shaﬁ Ahmed, Mohamed A. Thaha. Academic Surgical Unit, Blizard Institute,
National Centre for Bowel Research & Surgical Innovations (NCBRSI), Barts
and The London SMD, Queen Mary University London, UK, & The Royal London
Hospital, London, UK.
Introduction: With an ageing population diagnosed with cancer, rigorous
co-morbidity assessment is cornerstone to optimising treatment and
improving quality of survivorship. The study primarily aimed to determine
the feasibility of routine co-morbidity data collection using the validated
ACE-27 questionnaire. Secondary aims included determining the optimal
time and method of data collection.
Methods: A retrospective mapping exercise (phase I; 6-months) examined
the co-morbidity data availability within the MDT. Phase II prospectively
collected co-morbidity data using ACE-27 for a 3-month period.
Results: In phase I, 73/135(54%) patients had co-morbidity data available
informing the MDT discussion. In 62-patients with no co-morbidity data,
assessment revealed 41(30%) to have co-morbidities including > 2 major
system disorders in 21(16%) patients. Common referral sources to the MDT
were surgical out-patients (42%), and endoscopy (13%). The average lead
time from referral to index MDT discussion was 14-days. In phase II, ACE-
27 was administered in 50-patients, mean age-54-years (range 20-84).
Male: female ratio 26: 24. Average time to administer ACE-27 was 4.8-
minutes (range 1-15).
Conclusions: The phase I study conﬁrmed the previously widely
acknowledged view of poor co-morbidity data availability within a CRC
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morbidity data using ACE-27.
1119: DIFFERENTIAL EXPRESSION AND FUNCTION OF MONOCARBOXY-
LATE TRANSPORTER 1 (MCT1) IN HUMAN COLON
Naomi Fearon*,1, Elizabeth Ryan 1, Gavin Stewart 2, Des Winter 1,
Alan Baird 2. 1St Vincents University Hospital, Dublin, Ireland; 2University
College Dublin, Dublin, Ireland.
Introduction: Butyrate, a short-chain fatty acid, is produced by fermen-
tative bacteria in the colon, and is the primary energy source for colono-
cytes. It is transported across the colonic epithelium by monocarboxylate
transporter 1(MCT1). Optimal butyrate production and transport is
imperative for maintenance of gut health.
Methods: Western blot studies and immunohistochemistry detected
expression of MCT1 transporters in the human colon. Butyrate ﬂux studies
were carried out by mounting fresh human colon samples in Using
Chambers. Bidirectional ﬂux was investigated using radiolabelled butyrate
(C14) and Papp determined by using a scintillation counter.
Results: Immunohistochemistry andWestern blotting showed differential
expression of MCT1 throughout the colon. There was stronger expression
in the ascending colon compared to the descending colon (p<0.01, n¼3).
Butyrate ﬂux was bidirectional and was signiﬁcantly greater in the
ascending colon compared to the descending colon (p<0.05, n¼6). Flux
was inhibited by the known butyrate inhibitor Resveratrol.
Conclusions: These results illustrate differential expression of MCT1 in the
human colon, strongly correlating to regions that contain the largest
populations of intestinal bacteria.
1126: COLORECTAL CANCER OPERATIVE NOTES: PRELIMINARY AUDIT
RESULTS
Jessica Veitch*, Thomas Barnes, Nicola Eardley, Michael Johnson,
Chris McFaul, Dale Vimalachandran. Countess of Chester NHS Foundation
Trust, Chester, UK.
Introduction: Structured operative notes are imperative to provide clear
documentation of intraoperative events. In colorectal cancer they are vital
to plan post-operative management and future follow-up as well as aiding
data collection. This audit will assess colorectal cancer operative note
documentation in accordance with Association of Coloproctology (ACP)
Guidelines.
Methods: 50 colorectal resections performed between September 2012
and September 2013 were randomly selected for audit and operative notes
reviewed retrospectively. From these results an operative note proforma
was produced in accordance with ACP guidelines. A re-audit is ongoing
auditing all resections performed since November 2013 with this proforma
in use. Preliminary second cycle results are presented (n¼15).
Results: Full name, DOB and hospital number documentation improved
from 51%, 31% and 39% respectively to 100% each in the second cycle.
Surgeon name was 100% in both cycles though surgeon grade improved
from 2% to 87%. Operation date improved from 71% to 100% and start/end
time improved from 0% to 87%. Operation intention improved from 16% to
87%. Extent of malignancy improved from 61% to 87%.
Conclusions: Preliminary results show that an operative note proforma
has improved documentation in all domains. On-going audit is required to
conﬁrm this.
1139: THE ADDITIONAL YIELD OF WHOLE COLONIC IMAGING TWO
WEEK RULE (TWR) COLORECTAL ASSESSMENT
Nadeem Al-Khafaji*,2, Leonard Quinn 1, Adnan Sheikh 1, Paul Rooney 1.
1Royal Liverpool University Hospital, Liverpool, UK; 2University of Liverpool,
Liverpool, UK.
Introduction: Whole Colonic Investigation (WCI) following negative
Flexible Sigmoidoscopy (FS) in symptomatic patients is thought to have a
low diagnostic yield. We assessed the adequacy of FS in symptomatic TWR
patients and additional yield of neoplasia gained with WCI.
Methods: 2151 TWR patients from January 2012 to June 2013 were ana-
lysed, 404 excluded for non-attendance and anaemia. Endpoints were age-
stratiﬁed FS outcomes and additional colonic/extra-colonic neoplastic
yield of WCI.
Results: 1747 symptomatic patients were included (median age 65) with
91 colorectal cancers. WCI was undertaken in 974(55.8%) patients
following FS. FS initially identiﬁed 285 patients with colorectal neoplasia.Subsequent WCI identiﬁed 112 additional patients. The additional yield of
WCI compared to FS was signiﬁcantly greater, 29 in the 70-79year group
(p¼0.006), 41 in the 60-69year group (p¼0.001) and 28 in the 50-59 year
group (p¼0.01) (Chi-square). In >80year and <49year groups, WCI did not
confer signiﬁcant beneﬁt. 15 missed colorectal and 40 extra-colonic pri-
maries were identiﬁed by WCI.
Conclusions: WCI identiﬁed signiﬁcant numbers of patients with colo-
rectal neoplasia following negative FS. Investigating with FS alone results
in unacceptably high missed colonic and extra-colonic cancers. The role of
FS alone in colorectal TWR workup needs reassessment.
1157: COLORECTAL CANCER IN THE ELDERLY AND THE INFLUENCE OF
LEAD TIME BIAS: BETTER SURVIVAL DOES NOT EQUATE WITH
IMPROVED LIFE EXPECTANCY
K. Knight*, R. Oliphant, F. Maxwell, C. McKenzie, T. Sharma, A. Macdonald.
Lanarkshire Colorectal Study Group, Monklands Hospital, Airdrie, UK.
Introduction: To deﬁne outcomes in all patients presenting with colorectal
cancer aged 80 years at time of diagnosis based on treatment received.
Methods: Patients aged80 diagnosed with colorectal cancer in one acute
hospital trust between 1998 and 2011 were identiﬁed from a prospectively
maintained database. Primary endpoints were age at diagnosis, age at
death/censor and mortality at 30, 90 and 365 days.
Results: Of 668 patients, 412 (61.7%) underwent surgery, 44 (6.6%)
received endoscopic therapy and 212 (31.7%) had no active treatment.
Mean age at diagnosis was younger in those undergoing surgical resection
(83.7 years) compared to those having defunctioning surgery (84.9 years;
P¼0.043), endoscopic therapy (85.1 years; P¼0.008) or those managed
non-surgically (85.6 years; P<0.001). There was no signiﬁcant difference in
mean age of death or censor between groups. 1-year mortality in those
undergoing surgical resection was 30.1% compared to 67.7% in the
defunctioning group, 76.9% after bypass surgery and 63.2% in those who
had no active treatment (Log rank P<0.001).
Conclusions: There was no signiﬁcant difference in age at death or censor
between treatment groups among patients aged 80 presenting with
colorectal cancer, suggesting that differences in observed survival time are
heavily inﬂuenced by lead-time bias.
1233: I’D RATHER TAKE THE STAIRS e AN ALTERNATIVE TO CARDIOPUL-
MONARY EXERCISE TESTING
Alastair Morton*,1, Charles Maxwell-Armstrong 2, Damian Bragg 2,
Chris Harber 2. 1University of Nottingham, Nottingham, UK; 2Nottingham
University Hospitals Trust, Nottingham, UK.
Introduction: To investigate whether a short exercise test and peak
expiratory ﬂow rate (PEFR) can predict post-operative complications in
elective major abdominal surgery.
Methods: 58 patients scheduled for major abdominal surgery aged over 40
were recruited. In addition to the normal preoperative evaluation, patients'
rates of heart rate recovery (HRR) were recorded for twominutes following
a rapid climb of two ﬂights of stairs. Preoperative and postoperative PEFR,
incidence of complications and length of stay (LOS) were recorded.
Results: 48 patients were suitable for analysis; 40 had valid HRR data.
Complications occurred in 24/48 patients (50%). The mean rate of HRR was
signiﬁcantly lower in those who subsequently developed complications
(2.880±1.577 b.p.m/15secs) compared to those who did not (4.493±1.306
b.p.m/15secs) (t (38)¼3.473, p¼0.001), a mean difference of 1.614 (95%CI
0.673-2.554). When adjusted for severity of complication, the R2 value of
association was 0.371 (p<0.001). In patients with co-morbidities, preop-
erative PEFR was 29.7% lower in those who developed complications
(p¼0.022, 95% CI 5.09%-54.31%).
Conclusions: The HRR rate is a quick and cheap alternative to cardiopul-
monary exercise testing to screen for post-operative complication risk.
More data is needed to assess the impact on LOS. PEFR was predictive of
complications in those with co-morbidities.
1248: SURGEON VERSUS GASTROENTEROLOGY COLONOSCOPISTS e DO
SURGEONS NEED TO TRAIN IN ENDOSCOPY?
Qamar Zaman*,1, Aftab Khan 2, Daniel Thomas 1, Rajab Kerwat 1,
Hamid Khawaja 1, John Payne 1. 1Queen Mary Hospital, London, UK;
2University College London, London, UK.
Introduction: To compare the colonoscopy service provision between
gastroenterologists and surgeons at a district general hospital.
